Assignee
CIDARA THERAPEUTICS INC
US·17 granted patents·23 pending applications·93 citations·filing 2013–2023
Top patents by PatentIndex Score
40 records- 0194US10702573B2Dosing regimens for echinocandin class compoundsCIDARA THERAPEUTICS INC·Filed 2018·Granted Jul 7, 2020·8 cites·9 claims
- 0293US9676821B2Antifungal agents and uses thereofCIDARA THERAPEUTICS INC·Filed 2015·Granted Jun 13, 2017·13 cites·13 claims
- 0392US10016479B2Dosing regimens for echinocandin class compoundsCIDARA THERAPEUTICS INC·Filed 2016·Granted Jul 10, 2018·12 cites·17 claims
- 0492US9217014B2Antifungal agents and uses thereofCIDARA THERAPEUTICS INC·Filed 2014·Granted Dec 22, 2015·16 cites·34 claims
- 0591US11197909B2Compositions and methods for the treatment of fungal infectionsCIDARA THERAPEUTICS INC·Filed 2018·Granted Dec 14, 2021·5 cites·23 claims
- 0690US11833213B2Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2021·Granted Dec 5, 2023·3 cites·10 claims
- 0790US9526835B2Dosing regimens for echinocandin class compoundsCIDARA THERAPEUTICS INC·Filed 2013·Granted Dec 27, 2016·13 cites·18 claims
- 0889US10780144B2Methods for preventing and treating pneumocystis infectionsCIDARA THERAPEUTICS INC·Filed 2019·Granted Sep 22, 2020·8 cites·17 claims
- 0989US10369188B2Methods for preventing and treating pneumocystis infectionsCIDARA THERAPEUTICS INC·Filed 2017·Granted Aug 6, 2019·8 cites·26 claims
- 1088US11524980B2Synthesis of echinocandin antifungal agentCIDARA THERAPEUTICS INC·Filed 2019·Granted Dec 13, 2022·5 cites·23 claims
- 1188US11510992B1Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2021·Granted Nov 29, 2022·2 cites·35 claims
- 1282US12569565B2Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2023·Granted Mar 10, 2026·0 cites·14 claims
- 1375US12427200B2Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2022·Granted Sep 30, 2025·0 cites·20 claims
- 1471US11654196B2Dosing regimens for echinocandin class compoundsCIDARA THERAPEUTICS INC·Filed 2020·Granted May 23, 2023·0 cites·3 claims
- 1570US11819533B2Compositions and methods for the treatment of fungal infectionsCIDARA THERAPEUTICS INC·Filed 2021·Granted Nov 21, 2023·0 cites·13 claims
- 1667US2024076347A1Methods for preventing fungal infectionsCIDARA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1767US2023405082A1Methods for preventing and treating intra-abdominal candidiasisCIDARA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1867US2024108684A1Dosing regimens for treatment of fungal infectionsCIDARA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1963US2021220478A1Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2063US2021228727A1Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2162US2026000781A1Fc conjugates including an inhibitor of cd73 and uses thereofCIDARA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2261US2017253635A1Antifungal agents and uses thereofCIDARA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2361US2023181689A1Single dose methods for preventing and treating fungal infectionsCIDARA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2456US12060439B2Polymorph of echinocandin antifungal agentCIDARA THERAPEUTICS INC·Filed 2019·Granted Aug 13, 2024·0 cites·5 claims
- 2556US2024024497A1Methods for the synthesis of protein-drug conjugatesCIDARA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2656US2024174730A1Variant fc domains and uses thereofCIDARA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2756US2023364251A1Methods for the synthesis of protein-drug conjugatesCIDARA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2855US2024285786A1Protein-drug conjugates for antiviral therapyCIDARA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2954US2022175943A1Variant fc domains and uses thereofCIDARA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3053US11712459B2Dosing regimens for treatment of fungal infectionsCIDARA THERAPEUTICS INC·Filed 2017·Granted Aug 1, 2023·0 cites·4 claims
- 3153US2020164023A1Methods for preventing and treating intra-abdominal candidiasisCIDARA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3253US2021002346A1Methods for preventing fungal infectionsCIDARA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3349US2023079107A1Compositions and methods for the treatment of human immunodeficiency virusCIDARA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3449US2016213742A1Compositions and methods for the treatment of fungal infectionsCIDARA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3549US2023082611A1Compositions and methods for the treatment of respiratory syncytial virusCIDARA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3647US2023165970A1Compositions and methods for the treatment of bacterial infectionsCIDARA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3744US2023190950A1Compositions and methods for the treatment of bacterial infectionsCIDARA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3842US2019307843A1Single dose methods for preventing and treating fungal infectionsCIDARA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3940US2019374601A1Methods for treating fungal infectionsCIDARA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4039US2018256673A1Methods for treating fungal infectionsCIDARA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →